Shares of Novo Nordisk fell 14% on Tuesday after the company forecast lower sales and profit growth for the current year. The decision has raised concerns among investors about the company's future direction. Analysts note that this may be due to increased competition in the pharmaceutical market. The company has also faced issues related to patent protection for some of its key products.
Novo Nordisk shares fall 14% on profit growth forecast
Shares of pharmaceutical giant Novo Nordisk plummeted 14% on Tuesday after the company announced a forecast for lower sales and profit growth this year. Investors reacted to the news with a sharp drop in stock prices.